Targeting the androgen receptor in triple-negative breast cancer: current perspectives

Overview of attention for article published in OncoTargets and therapy, September 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 99 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 52 publications that cite this research output.

52

The most recent citing publications are shown below. View all 52 publications that cite this research output on Dimensions.

Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes

Article in Life Sciences (May 2024)

Androgen receptor signaling blockade enhances NK cell-mediated killing of prostate cancer cells and sensitivity to NK cell checkpoint blockade

Preprint in bioRxiv (November 2023)

Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype

Article in Cell Reports (November 2023)